Respiratory mucosal immunity and novel vaccination strategies against pulmonary tuberculosis
Respiratory mucosal immunity and novel vaccination strategies against pulmonary tuberculosis
批准号:
353762
负责人:
Xing Zhou
金额:
$179.41万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2023-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Lung tuberculosis (TB) is a leading infectious cause of morbidity and mortality in the developing countries and parts of developed countries including Canada despite decades-long use of BCG vaccine and antibiotics. Multi-drug resistant TB and HIV epidemic
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
-
批准号:442864
-
项目类别:Operating Grants
-
资助金额:$3.64万
-
财政年份:2021
-
负责人:Xing Zhou
-
依托单位:
Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
-
批准号:430637
-
项目类别:Operating Grants
-
资助金额:$139.94万
-
财政年份:2020
-
负责人:Xing Zhou
-
依托单位:
Novel multivalent chimpanzee adenovirus-based vaccines against pulmonary tuberculosis
-
批准号:343353
-
项目类别:Operating Grants
-
资助金额:$63.77万
-
财政年份:2016
-
负责人:Xing Zhou
-
依托单位:
Unraveling the immune mechanisms of delayed onset of T cell immunity against pulmonary tuberculosis
-
批准号:266062
-
项目类别:Operating Grants
-
资助金额:$51.79万
-
财政年份:2012
-
负责人:Xing Zhou
-
依托单位:
Bioengineered chimpanzee adenovirus-based vaccines against tuberculosis: Optimization of immunologic property, formulation and delivery for bench-to-human applications
-
批准号:269861
-
项目类别:Operating Grants
-
资助金额:$35.46万
-
财政年份:2012
-
负责人:Xing Zhou
-
依托单位:
Novel Strategies to Enhance BCG Vaccine-induced Mucosal Immunity against Pulmonary Tuberculosis
-
批准号:211557
-
项目类别:Operating Grants
-
资助金额:$54.5万
-
财政年份:2010
-
负责人:Xing Zhou
-
依托单位:
海外基金